Conventional Chemotherapy
Showing 1 - 25 of >10,000
Bone Cancer Trial in Villejuif (regorafenib tablet)
Recruiting
- Bone Cancer
- regorafenib tablet
-
Villejuif, Ile De France, FranceGustave Roussy
Apr 13, 2023
Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +9 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 21, 2023
Acute Myeloid Leukemia Trial in Baltimore, Houston (Atovaquone, Cytarabine, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia
- Atovaquone
- +4 more
-
Baltimore, Maryland
- +1 more
Oct 7, 2022
Advanced Gastric Cancer Trial in Seoul (Intergrate early palliatuve care + Conventional chemo, Conventional chemo)
Recruiting
- Advanced Gastric Cancer
- Intergrate early palliatuve care + Conventional chemotherapy
- Conventional chemotherapy
-
Seoul, Korea, Republic ofYonsei Cancer Center, Yonsei University College of Medicine
Oct 17, 2022
DESTINY Breast Respond HER2-low Europe
Not yet recruiting
- Unresectable Breast Cancer
- +2 more
- Trastuzumab deruxtecan
- (no location specified)
Jul 6, 2023
Allo-HSCT as First-line Consolidation in High-risk PTCL
Recruiting
- T Cell Lymphoma
-
Beijing, ChinaPeking University People's Hospital
Jul 31, 2022
Acute Myeloid Leukemia Trial in Stanford (Talazoparib, Topotecan, Gemcitabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Talazoparib
- +2 more
-
Stanford, CaliforniaStanford University
Jun 10, 2022
Acute Myeloid Leukemia Trial in Germany (MODULE: conventional chemo (Cytarabine+Daunorubicin) in combination with
Active, not recruiting
- Acute Myeloid Leukemia
- MODULE: conventional chemotherapy (Cytarabine+Daunorubicin) in combination with midostaurin+GO
- +4 more
-
München, Bayern, Germany
- +10 more
Aug 31, 2021
Precursor Cell Lymphoblastic Leukemia Trial in Germany (Inotuzumab ozogamicin)
Recruiting
- Precursor Cell Lymphoblastic Leukemia
- Inotuzumab ozogamicin
-
Augsburg, Germany
- +13 more
Oct 31, 2022
Oropharyngeal Cancer Trial in Shanghai (Toxicities reduced treatment, Conventional treatment)
Recruiting
- Oropharyngeal Cancer
- Toxicities reduced treatment
- Conventional treatment
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Nov 26, 2023
Ovarian Cancer Trial in Chongqing (Autologous blood transfusion with haematopoietic stem cells)
Recruiting
- Ovarian Cancer
- Autologous blood transfusion with haematopoietic stem cells
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
May 29, 2022
NSCLC Trial in Ostrava (primary tumour radiotherapy, stereotactic body radiotherapy, maintenance radiotherapy)
Recruiting
- Non-small Cell Lung Cancer
- primary tumour radiotherapy
- +2 more
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Dec 6, 2022
Glioblastoma Multiforme, Adult Trial in Shijiazhuang (Tumor Infiltrating Lymphocytes (TIL))
Recruiting
- Glioblastoma Multiforme, Adult
- Tumor Infiltrating Lymphocytes (TIL)
-
Shijiazhuang, Hebei, ChinaThe Second Hospital of HeBei Medical University
Apr 11, 2022
Breast Tumor, Exercise Trial in Stockholm (Whole Body Vibration exercise - WBV)
Recruiting
- Breast Neoplasm, Exercise
- Whole Body Vibration exercise - WBV
-
Stockholm, SwedenKarolinska University Hospital
Jan 2, 2023
Arsenic Trioxide, Childhood ALL Trial in Guangzhou (Realgar Indigo naturalis formula, Conventional chemo)
Recruiting
- Arsenic Trioxide
- Childhood ALL
- Realgar Indigo naturalis formula
- Conventional chemotherapy
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jan 10, 2023
Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)
Recruiting
- Acute Myeloid Leukemia (AML) in Remission
- Azacitidine
- +2 more
-
Suzhou, Jiangsu, China
- +1 more
Aug 18, 2022
AML, Adult, Chemo Effect Trial in Suzhou (Venetoclax, Decitabine for Injection, Cytarabine)
Recruiting
- AML, Adult
- Chemotherapy Effect
- Venetoclax
- +3 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Feb 28, 2022
Chronic Lymphocytic Leukemia Trial in Perugia (ITF2357)
Terminated
- Chronic Lymphocytic Leukemia
-
Perugia, ItalyDepartment of Internal Medicine and Public Health, University of
Jan 18, 2022
Breast Cancer Trial (use of a smartphone app for adverse event management, conventional adverse event management)
Not yet recruiting
- Breast Cancer
- use of a smartphone app for adverse event management
- conventional adverse event management
- (no location specified)
Feb 16, 2022
Locally Advanced Gastric Carcinoma Trial in Hanzhou (Oxaliplatin by arterial infusion plus S-1, SOX neoadjuvant, gastrectomy
Not yet recruiting
- Locally Advanced Gastric Carcinoma
- Oxaliplatin by arterial infusion plus S-1
- +3 more
-
Hanzhou, Zhejiang, ChinaGastrointestinal Department of Second Affiliated Hospital of Zhe
Oct 20, 2022
Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,
Recruiting
- Gastric Adenocarcinoma
- +4 more
- Capecitabine
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 20, 2022
Mucositis Trial in Alexandria (Simpler diode laser, Conventional symptomatic treatment)
Completed
- Mucositis
- Simpler diode laser
- Conventional symptomatic treatment
-
Alexandria, EgyptFaculty of Dentistry, Alexandria University
Dec 20, 2021
Breast Cancer Trial in Duarte (biological, drug, procedure)
Active, not recruiting
- Breast Cancer
- filgrastim
- +10 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Feb 17, 2022
Sarcoma Trial in Baltimore, Minneapolis (biological, drug, procedure, radiation)
Active, not recruiting
- Sarcoma
- pegfilgrastim
- +5 more
-
Baltimore, Maryland
- +1 more
Mar 25, 2022